Cargando…
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406051/ https://www.ncbi.nlm.nih.gov/pubmed/34476096 http://dx.doi.org/10.1093/ckj/sfab104 |
| _version_ | 1783746443459166208 |
|---|---|
| author | Wanner, Christoph Cooper, Mark E Johansen, Odd Erik Toto, Robert Rosenstock, Julio McGuire, Darren K Kahn, Steven E Pfarr, Egon Schnaidt, Sven von Eynatten, Maximilian George, Jyothis T Gollop, Nicholas D Marx, Nikolaus Alexander, John H Zinman, Bernard Perkovic, Vlado |
| author_facet | Wanner, Christoph Cooper, Mark E Johansen, Odd Erik Toto, Robert Rosenstock, Julio McGuire, Darren K Kahn, Steven E Pfarr, Egon Schnaidt, Sven von Eynatten, Maximilian George, Jyothis T Gollop, Nicholas D Marx, Nikolaus Alexander, John H Zinman, Bernard Perkovic, Vlado |
| author_sort | Wanner, Christoph |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8406051 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84060512021-09-01 Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial Wanner, Christoph Cooper, Mark E Johansen, Odd Erik Toto, Robert Rosenstock, Julio McGuire, Darren K Kahn, Steven E Pfarr, Egon Schnaidt, Sven von Eynatten, Maximilian George, Jyothis T Gollop, Nicholas D Marx, Nikolaus Alexander, John H Zinman, Bernard Perkovic, Vlado Clin Kidney J Erratum Oxford University Press 2021-07-14 /pmc/articles/PMC8406051/ /pubmed/34476096 http://dx.doi.org/10.1093/ckj/sfab104 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Erratum Wanner, Christoph Cooper, Mark E Johansen, Odd Erik Toto, Robert Rosenstock, Julio McGuire, Darren K Kahn, Steven E Pfarr, Egon Schnaidt, Sven von Eynatten, Maximilian George, Jyothis T Gollop, Nicholas D Marx, Nikolaus Alexander, John H Zinman, Bernard Perkovic, Vlado Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title_full | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title_fullStr | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title_full_unstemmed | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title_short | Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| title_sort | erratum to: effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406051/ https://www.ncbi.nlm.nih.gov/pubmed/34476096 http://dx.doi.org/10.1093/ckj/sfab104 |
| work_keys_str_mv | AT wannerchristoph erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT coopermarke erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT johansenodderik erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT totorobert erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT rosenstockjulio erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT mcguiredarrenk erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT kahnstevene erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT pfarregon erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT schnaidtsven erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT voneynattenmaximilian erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT georgejyothist erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT gollopnicholasd erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT marxnikolaus erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT alexanderjohnh erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT zinmanbernard erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial AT perkovicvlado erratumtoeffectoflinagliptinversusplacebooncardiovascularandkidneyoutcomesinnephroticrangeproteinuriaandtype2diabetest2dthecarmelinarandomisedcontrolledtrial |